Caulis Sinomenii extracts activate DA/NE transporter and inhibit 5HT transporter

Experimental Biology and Medicine

Volumn 234, Issue 8, 2009, Pages 976-985

  Zhao, Gang ^a,b   Bi, Cheng ^a   Qin, Guo Wei ^c   Guo, Li He ^a,b  

^a Cell Star Bio Technologies Co Limited   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Caulis Sinomenii; Dopamine; Norepinephrine; Reuptake modulator; Serotonin; Transporter

Indexed keywords

DOPAMINE TRANSPORTER; NORADRENALIN TRANSPORTER; PLANT EXTRACT; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SINOMENII EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; NEUROTRANSMITTER UPTAKE; NONHUMAN; PLANT STEM; SINOMENIUM;

ANIMALS; BIOGENIC MONOAMINES; BIOLOGICAL TRANSPORT; CHEMICAL FRACTIONATION; CHO CELLS; CRICETINAE; CRICETULUS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MICE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PLANT EXTRACTS; RATS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SINOMENIUM;

EID: 68149128513     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0903-RM-92     Document Type: Article

References (32)

1. The Pharmacopoeia Committee of China. The Chinese Pharmacopoeia (English ed.). Beijing, China: Chemical Industry Publishing House, Vol I:pp21, 2000.
2. Li RW, David Lin G, Myers SP, Leach DN. Anti-inflammatory activity of Chinese medicinal vine plants. J Ethnopharmacol 85:61-67, 2003.
3. Liu L, Resch K, Kaever V. Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine. Int J Immunopharmacol 16:685-691, 1994.
4. Liu L, Buchner E, Beitze D, Schmidt-Weber CB, Kaever V, Emmrich F, Kinne RW. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int J Immunopharmacol 18:529-543, 1996.
5. Mark W, Schneeberger S, Seiler R, Stroka DM, Amberger A, Offner F, Candinas D, Margreiter R. Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection. Transplantation 75:940-945, 2003.
6. Liu JH, Li WD, Teng HL, Lin ZB. Immunopharmacological action of sinomenine, an alkaloid isolated from Sinomenium acutum, and its mechanism of action in treating rheumatoid arthritis. Yao Xue Xue Bao 40:127-131, 2005.
7. Zeng Y, Gu B, Ji X, Ding X, Song C, Wu F. Sinomenine, an antirheumatic alkaloid, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalolmyelitis. Biol Pharm Bull 30:1438-1444, 2007.
8. Mo ZX, An SL, Zhou JY. Effects of Caulis Sinomenii and sinomenine on morphine-induced place preference and brain histamine level in mice. Nan Fang Yi Ke Da Xue Xue Bao 26:1709-1713, 2006.
9. Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci 8:844-858, 2007.
10. Goodman A. Neurobiology of addiction. An integrative review. Biochem Pharmacol 75:266-322, 2008.
11. Marien MR, Colpaert FC, Rosenquist AC. Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Rev 45:38-78, 2004.
12. Hersch, SM, Yi H, Heilman CJ, Edwards RH, Levey AI. Subcellular localization and molecular topology of dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388:211-227, 1997.
13. Nelson N. The family of Na+/Cl- neurotransmitter transporters. J Neurochem 71:1785-1803, 1998.
14. Zhang YQ, Zhang N, Mao QM. Content determination of Sinomenine of QINGFENGTENG by RP-HPLC. HeiLongJiang Med J 15:248, 2002.
15. Liu Z, Wang Y, Zhao W, Ding J, Mei Z, Guo L, Cui D, Fei J. Peptide derived from insulin with regulatory activity of dopamine transporter. Neuropharmacology 41:464-471, 2001.
16. Xu LF, Chu WJ, Qing XY, Li S, Wang XS, Qing GW, Fei J, Guo LH. Protopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice models. Neuropharmacology 50:934-940, 2006.
17. Zhao G, Jiang ZH, Zheng XW, Zang SY, Guo LH. Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract. Pharmacol Biochem Behav 90:363-371, 2008.
18. Zhao G, Zang SY, Zheng XW, Zhang, XH, Guo LH. Bakuchiol analogs inhibit monoamine transporters and regulate monoaminergic functions. Biochem Pharmacol 75:1835-1847, 2008.
19. Wang Y, Zhou LL, Li R. Study progress in Sinomenium acutum (Thunb.) Rehd. et Wils. Zhong Yao Cai 25:209-211, 2002.
20. Torres GE. The dopamine transporter proteome. J Neurochem 97:3-10, 2006.
21. Gainetdinov RR, Caron MG. Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 43:261-284, 2003.
22. Kienast T, Heinz A. Dopamine and the diseased brain. CNS Neurol Disord Drug Targets 5:109-131, 2006.
23. Nutt DJ, Bell CJ, Malizia AL. Brain mechanisms of social anxiety disorder. J Clin Psychiatry 59 Suppl 17:4-11, 1998.
24. Harsányi A, Csigó K, Demeter G, Németh A. New approach to obsessive-compulsive disorder: dopaminergic theories. Psychiatr Hung 22:248-258, 2007.
25. Alcaro A, Huber R, Panksepp J. Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Rev 56:283-321, 2007.
26. Stefano GB, Bianchi E, Guarna M, Fricchione GL, Zhu W, Cadet P, Mantione KJ, Casares FM, Kream RM, Esch T. Nicotine, alcohol and cocaine coupling to reward processes via endogenous morphine signaling: the dopamine-morphine hypothesis. Med Sci Monit 13:RA91-102, 2007.
27. Wang YS. Pharmacology and Applications of Chinese Materia Medica. Beijing: People's Health Publisher, pp609-614, 1983.
28. Zhu YP. Chinese Materia Medica: Chemistry, pharmacology and applications. Boca Raton/London/New York/Washington DC: CRC Press, pp288-289, 1998.
29. Chen SW, Mi XJ, Wang R, Wang WJ, Kong WX, Zhang YJ, Li YL. Behavioral effects of sinomenine in murine models of anxiety. Life Sci 78:232-238, 2005.
30. Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258, 1997.
31. 3H]carboxymethoxy-3 beta-(4-fluorophenyl) tropane to the seronin transporter. Mol Pharmacol 40:421-426, 1991.
32. Rösser N, Flöel A. Pharmacological enhancement of motor recovery in subacute and chronic stroke. NeuroRehabilitation 23:95-103, 2008.